Dose 0.05 mg/kg up to 2 mg IV/PO every 4 to 8 hours as needed Status Epilepticus Start 0.05 to 0.1 mg/kg IV up to 4 mg over 2 to 5 minutes May repeat 0.05 mg/kg IV up to 4 mg in 10 min if needed VI. Dosing: Equivalent (for Benzodiazepine Withdrawal) Valium = Dose x5.0...
Sprinkle dose option1 Patients have the option to open the capsule and sprinkle the entire contents over a tablespoon of applesauce, followed by drinking water Do not crush or chew LOREEV XR To switch patients from lorazepam IR to LOREEV XR: Discontinue lorazepam immediate-release (IR) tablets...
Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med 30: 997–1006. Article CAS Google Scholar Ahveninen J, Escera C, Polo MD, Grau C, Jääskeläinen IP (2000). Acute ...
Both lorazepam and Xanax should only be used short-term due to risk of addiction and dependence. Generally speaking, benzodiazepines with a shorter half life (such as lorazepam and Xanax) are harder to stop than those with a longer half life (such as diazepam). Both lorazepam and Xanax ...
These effects also resolved rapidly, being similar to placebo by 4 to 6 hours after dosage. Sedative and DSST-impairing effects of lorazepam were of slower onset but longer duration than those of alprazolam. After oral prazepam, appearance of desmethyldiazepam in plasma was slow, with minimal ...
A retrospective study was performed to compare intravenous lorazepam and intravenous diazepam in the treatment of status epilepticus. Forty-five episodes o... DW Giang,MC Mcbride - 《Pediatric Neurology》 被引量: 158发表: 1988年 Lorazepam for seizure prophylaxis during high-dose busulfan administration...
(primarily drowsiness and oversedation) with both drugs is similar, and appears to be dose-dependent. A few of the studies suggest that lorazepam has greater efficacy and possibly less unwanted toxicity than diazepam, but this is not a consistent finding. Lorazepam has been extensively evaluated ...
We found lorazepam modulated the intensity of participants' threat-avoidance behavior in a dose-dependent manner. However, the pattern of effects depended upon two factors: type of threat-avoidance behavior and theoretically relevant measures of personality. In the case of flight behavior (one-way ...